BREVAGenplus is a genetic test that can determine a woman’s risk of developing breast cancer over the next 5 years of her life.
As the average woman approaches 60 years of age, her risk of breast cancer over the next 5 years hovers around the high risk threshold based on age alone.
What do my Results Mean?
If your results come back showing that you are at increased risk of developing breast cancer over the next 5 years of your life, there are management plans that can reduce your risk of developing breast cancer.
It is important to know that if your results come back as increased risk, it does NOT mean that you have breast cancer or will definitely develop breast cancer. It simply shows that you are at an increased risk of developing breast cancer.
The good news is that with this knowledge, your healthcare provider will work with you to develop a personal plan to reduce your risk of developing breast cancer.
Some of the suggestions may include:
- Medication that may reduce your breast cancer risk.
- Lifestyle changes (i.e. increased exercise, reduced alcohol intake, a healthy body weight)
BREVAGenplus is a simple cheek swab administered at your healthcare provider’s office. Please download a patient brochure today and ask your healthcare provider about breast cancer risk assessment on your next visit or contact us for additional information.
- BREVAGenplus provides information about breast cancer risk over a 5 year period; it does not diagnose breast cancer
- BREVAGenplus is validated in African American, Caucasian, and Hispanic women age 35 years or older
- The risk estimate used in this test does not take into account several other breast cancer risk factors, such as an extensive family history of breast and ovarian cancer and thus does not provide a lifetime risk score
- This test is used for clinical purposes
* BREVAGenplus is not applicable to women who are already at high risk of breast cancer including those that have a personal or extensive family history of breast and/or ovarian cancer, LCIS, DCIS, AH or have thoracic RT under 30y. Any women with these risk factors are already at increased risk of breast cancer and should be screened and followed as such.